Public-Private Partnerships for Vaccine Research

Public-private partnerships (PPPs) have emerged as an effective model for vaccine research and development. These partnerships bring together the expertise and resources of both the public and private sectors to accelerate the development of vaccines and improve access to them. PPPs can help to bridge the funding gap for vaccine development, share risks and rewards, and ensure that vaccines are affordable and accessible to all. They also facilitate collaboration between industry, academia, and government, leading to innovation and discovery. The success of PPPs in vaccine development highlights the importance of collaboration and cooperation in achieving global health goals.

    Related Conference of Public-Private Partnerships for Vaccine Research

    February 27-28, 2025

    8th International Conference on Vaccines and Immunology

    Paris, France
    April 28-29, 2025

    2nd Global Summit on Vaccines & Emerging Diseases

    Bali, Indonesia
    July 28-29, 2025

    43rd Euro Global Summit and Expo on Vaccines & Vaccination

    Aix-en-Provence, France
    September 18-19, 2025

    7th World Congress on Vaccine and Immunology

    Amsterdam, Netherlands

    Public-Private Partnerships for Vaccine Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in